← back to search

Pablo Pérez‐Martínez

Universidad de Sevilla · ES
Area of research
Public Health, Environmental and Occupational Health · Physiology
Research interest
Research interests include Nutritional Studies and Diet, Diet and metabolism studies, Diabetes, Cardiovascular Risks, and Lipoproteins, and Fatty Acid Research and Health.
h-index
61
citations
17,366
works
454
NIH funding
primary concept
email

Recent publications

Dietary Guidelines for Americans (DGA) 2025-2030: Similarities and contrasts with the recommendations document of the Spanish Society of Atherosclerosis (SEA) (2024 update).
2026cited by 0position: contributordoi
Dietary guidelines for Americans (DGA): 2025–2030: similarities and contrasts with the recommendations document of the Spanish society of atherosclerosis (SEA) (2024 update)
Clínica e Investigación en Arteriosclerosis (English Edition) 2026cited by 0position: contributordoi
Food Insecurity and Its Cardiovascular Implications in Underresourced Communities.
2025cited by 2position: contributordoi
Health inequity in metabolic disorders and lifestyle behaviors in under-resourced adolescents: a cross-sectional study from E-DUCASS Program
American Journal of Preventive Cardiology 2025cited by 1position: contributordoi
The impact of the school lunchroom as a health tool: synergies between public policy and the E-DUCASS program.
2025cited by 0position: contributordoi
Cumulative exposure to cholesterol: lost time cannot be recovered.
2025cited by 0position: contributordoi
El poder del comedor escolar como herramienta de salud: sinergias entre la política pública y el programa E-DUCASS
Revista Clínica Española 2025cited by 0position: contributordoi
Cumulative exposure to cholesterol: Lost time cannot be recovered
Clínica e Investigación en Arteriosclerosis (English Edition) 2025cited by 0position: contributordoi
Association between Diet Quality and Risk of Type 2 Diabetes Mellitus in Patients with Coronary Heart Disease: Findings from the CORDIOPREV Study.
2024cited by 5position: contributordoi
Telomere Maintenance Is Associated with Type 2 Diabetes Remission in Response to a Long-Term Dietary Intervention without Non-Weight Loss in Patients with Coronary Heart Disease: From the CORDIOPREV Randomized Controlled Trial.
2024cited by 4position: contributordoi
Dietary Lipid Quantity and Quality Modulate the Postprandial Metabolomic Profile in Patients with Metabolic Syndrome.
2024cited by 3position: contributordoi
Gut Microbiota Interacts with Dietary Habits in Screenings for Early Detection of Colorectal Cancer.
2024cited by 2position: contributordoi
Adherence to a Mediterranean lifestyle improves metabolic status in coronary heart disease patients: A prospective analysis from the CORDIOPREV study.
2023cited by 18position: contributordoi
Oral intake of <i>Lactiplantibacillus pentosus</i> LPG1 Produces a Beneficial Regulation of Gut Microbiota in Healthy Persons: A Randomised, Placebo-Controlled, Single-Blind Trial.
2023cited by 12position: contributordoi
Artificial sweeteners and cardiovascular risk.
2023cited by 9position: contributordoi
Changes in quantity plant-based protein intake on type 2 diabetes remission in coronary heart disease patients: from the CORDIOPREV study.
2023cited by 9position: contributordoi
Functional foods and nutraceuticals in the treatment of hypercholesterolemia: Statement of the Spanish Society of Arteriosclerosis 2023.
2023cited by 7position: contributordoi
Nutritional recommendations in the prevention and treatment of atherogenic dyslipidemia.
2023cited by 5position: contributordoi
Dietary modulation of advanced glycation end products metabolism on carotid intima-media thickness in type 2 diabetes patients: From the CORDIOPREV study.
2023cited by 4position: contributordoi
Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial.
2022cited by 397position: contributordoi
An altered microbiota pattern precedes Type 2 diabetes mellitus development: From the CORDIOPREV study.
2022cited by 35position: contributordoi
SEA 2022 Standards for Global Control of Cardiovascular Risk.
2022cited by 29position: contributordoi
Chronodisruption and diet associated with increased cardiometabolic risk in coronary heart disease patients: the CORDIOPREV study.
2022cited by 18position: contributordoi
Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study.
2022cited by 12position: contributordoi
Effect of the Mediterranean diet and probiotic supplementation in the management of mild cognitive impairment: Rationale, methods, and baseline characteristics.
2022cited by 8position: contributordoi
Long-term effect of a dietary intervention with two-healthy dietary approaches on food intake and nutrient density in coronary patients: results from the CORDIOPREV trial.
2022cited by 8position: contributordoi
Diet and vascular risk.
2022cited by 6position: contributordoi
High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study.
2022cited by 6position: contributordoi
A plasma fatty acid profile associated to type 2 diabetes development: from the CORDIOPREV study.
2022cited by 6position: contributordoi
Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry.
2022cited by 6position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

José López‐Miranda · Florida State University61 papers (2016–2024)Javier Delgado‐Lista · Instituto de Salud Carlos III48 papers (2016–2025)Juan F. Alcalá‐Díaz · Instituto de Salud Carlos III43 papers (2016–2025)Elena M. Yubero‐Serrano · Consejo Superior de Investigaciones Científicas28 papers (2016–2025) · 22 papers (2020–2024)Antonio Camargo · Instituto de Salud Carlos III16 papers (2016–2024) · 16 papers (2021–2026) · 13 papers (2019–2024) · 12 papers (2020–2025) · 11 papers (2020–2025) · 11 papers (2020–2024)María M. Malagón · Instituto Maimónides de Investigación Biomédica de Córdoba10 papers (2019–2025) · 9 papers (2020–2024)Pablo Perez-Martinez · 6 papers (2021–2023)Raúl M. Luque · University of Guelph6 papers (2019–2024) · 6 papers (2020–2025) · 6 papers (2020–2024)José María Ordovás · Anna Needs Neuroblastoma Answers5 papers (2020–2025)Juan L. Romero‐Cabrera · Instituto de Salud Carlos III4 papers (2021–2025)Silvia de la Cruz‐Ares · Secretaria de Salud4 papers (2020–2021)